Blog

T cells

How simpler implementations enable complex cell and gene therapies

After spending 12 years working in the biopharmaceutical industry – three of those here at Vineti – I’ve learned first-hand that cell and gene therapies (CGTs) present a unique environment for software implementation.st

Read More
June 26, 2019

Vineti joins the leadership of the Standards Coordinating Body

At Vineti, we’re pushing every day to help the field of advanced therapies — cell therapy, gene therapy, personalized cancer...

June 19, 2019

Cell therapy standards in action — a new case study on labeling

In cell therapy and gene therapy, in-process and final product labeling matters more to patient safety than ever before —...

June 12, 2019

ISCT 2019: data elements in the cell therapy value chain

I just got back from speaking at the International Society for Cell Therapy annual meeting, where the topic was next-gen data management....

June 4, 2019

Supply chain management readiness, Part 3: process

(Note: this post is the third part of a four-part series on supply chain planning for personalized therapies such as...

May 31, 2019

Cell therapy and gene therapy versus cancer: 10 numbers to watch

ASCO 2019 is here! In 2018, ASCO named CAR-T cell therapy the cancer Advance of the Year, and this year’s ASCO brings more cell...

May 30, 2019

When the patient is the product — some key challenges in cell and gene therapies

In personalized therapies — cell therapies, gene therapies, and neoantigen therapies — a patient is not just the recipient of...

May 22, 2019

Cell and gene therapy standards need you!

One week to go! In the next seven days, those of us working in cell and gene therapy have a...

May 15, 2019

Supply chain management readiness, Part 2: operational ecosystem

(Note: this post is the second part of a four-part series on supply chain planning for personalized therapies such as...

May 9, 2019

Cell and gene therapy news: some recent highlights

Things keep moving fast in the world of cell and gene therapy. Here are a few of the recent developments...

May 2, 2019

Commercial lessons for clinical-phase success, Part I: it all starts with collaboration

In early-phase clinical research, it’s common to think that your science resides within your lab. But when it comes to...

April 30, 2019

Q1 update from Vineti

As 2019 shapes up to be yet another landmark year for advanced therapies, Vineti is hard at work on our...

April 24, 2019

Supply chain management readiness, Part 1: strategy

There are many critical decisions to be made when moving a large-molecule biologic out of the lab into human trials....